$GCTK
GlucoTrack Inc Stock $gctk

$gctk Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000117891314001124 Filed on March 28, 2014

Income Statement

Concept	2014 Q1	2013 Q2	2013
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$436.1K	$370.5K	$1.041M
YoY Change	137.56%	48.2%	22.07%
% of Gross Profit
Research & Development	$451.1K	$461.3K	$1.987M
YoY Change	-10.54%	-9.27%	3.44%
% of Gross Profit
Depreciation & Amortization	$8.096K	$0.00	$33.68K
YoY Change	15.21%		31.86%
% of Gross Profit
Operating Expenses	$887.2K	$831.8K	$3.028M
YoY Change	28.98%	63.59%	9.17%
Operating Profit	-$887.2K	-$831.8K	-$3.028M
YoY Change	28.98%	10.31%	9.17%
Interest Expense	$150.0K	$260.0K	-$110.0K
YoY Change	-122.73%	1200.0%	450.0%
% of Operating Profit
Other Income/Expense, Net			-$6.660M
YoY Change			-22300.0%
Pretax Income	-$740.0K	-$580.0K	-$9.797M
YoY Change	-44.78%	-21.62%	253.38%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$736.9K	-$576.6K	-$9.797M
YoY Change	-45.15%	-21.81%	253.38%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.13	-$1.95
Diluted Earnings Per Share	-$1.64	-$0.13	-$1.95
COMMON SHARES
Basic Shares Outstanding	5.304M shares	5.298M shares	5.326M shares
Diluted Shares Outstanding		5.298M shares	5.326M shares

Balance Sheet

Concept	2014 Q1	2013 Q2	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.620M	$4.320M	$2.390M
YoY Change	-69.61%	468.42%	342.59%
Cash & Equivalents	$1.617M	$4.321M	$2.390M
Short-Term Investments
Other Short-Term Assets	$88.49K	$78.43K	$90.00K
YoY Change	22.04%	-21.57%	12.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.706M	$4.400M	$2.480M
YoY Change	-68.4%	411.59%	300.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.5K	$91.91K	$110.0K
YoY Change	64.05%	31.3%	57.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$170.0K	$170.0K	$170.0K
YoY Change	41.67%	54.55%	41.67%
Total Long-Term Assets	$276.7K	$258.0K	$280.0K
YoY Change	47.36%	43.35%	47.37%
TOTAL ASSETS
Total Short-Term Assets	$1.706M	$4.400M	$2.480M
Total Long-Term Assets	$276.7K	$258.0K	$280.0K
Total Assets	$1.982M	$4.658M	$2.760M
YoY Change	-64.51%	347.86%	240.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$135.6K	$174.9K	$50.00K
YoY Change	-5.19%	24.95%	-58.33%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$20.00K	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$505.9K	$548.7K	$310.0K
YoY Change	0.26%	52.42%	-32.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.990M	$2.800M	$9.150M
YoY Change	139.73%	221.84%	963.95%
Total Long-Term Liabilities	$8.991M	$2.796M	$9.150M
YoY Change	139.51%	221.34%	963.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$505.9K	$548.7K	$310.0K
Total Long-Term Liabilities	$8.991M	$2.796M	$9.150M
Total Liabilities	$9.497M	$3.344M	$9.460M
YoY Change	123.01%	171.9%	616.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.48M	-$17.59M
YoY Change	55.71%
Common Stock	$14.56M	$14.49M
YoY Change	-1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.87M	-$3.072M	-$6.700M
YoY Change
Total Liabilities & Shareholders Equity	$1.982M	$4.658M	$2.760M
YoY Change	-64.51%	347.86%	240.74%

Cashflow Statement

Concept	2014 Q1	2013 Q2	2013
OPERATING ACTIVITIES
Net Income	-$736.9K	-$576.6K	-$9.797M
YoY Change	-45.15%	-21.81%	253.38%
Depreciation, Depletion And Amortization	$8.096K	$0.00	$33.68K
YoY Change	15.21%		31.86%
Cash From Operating Activities	-$690.0K	-$870.0K	-$3.220M
YoY Change	6.91%	35.94%	40.18%
INVESTING ACTIVITIES
Capital Expenditures	$8.854K	$30.00K	$64.25K
YoY Change	1026.46%		466.25%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$40.00K	-$40.00K
YoY Change			300.0%
Cash From Investing Activities	-$10.00K	-$80.00K	-$100.0K
YoY Change	1172.26%	-900.0%	463.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-70.00K	-70.00K	5.060M
YoY Change	-101.3%		430.66%
NET CHANGE
Cash From Operating Activities	-690.0K	-870.0K	-3.220M
Cash From Investing Activities	-10.00K	-80.00K	-100.0K
Cash From Financing Activities	-70.00K	-70.00K	5.060M
Net Change In Cash	-770.0K	-1.020M	1.740M
YoY Change	-116.2%	61.9%	-227.83%
FREE CASH FLOW
Cash From Operating Activities	-$690.0K	-$870.0K	-$3.220M
Capital Expenditures	$8.854K	$30.00K	$64.25K
Free Cash Flow	-$698.9K	-$900.0K	-$3.284M
YoY Change	8.15%	40.62%	42.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001506983
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5304082	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	42798070	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	Integrity Applications, Inc.
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013Q4	igap	Area Of Leased Space AreaOfLeasedSpace	3100	sqft
CY2011	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.262	pure
CY2012	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.268	pure
CY2013	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.288	pure
CY2011	igap	Debt Instruments Convertible Interest Expense DebtInstrumentsConvertibleInterestExpense		USD
CY2012	igap	Debt Instruments Convertible Interest Expense DebtInstrumentsConvertibleInterestExpense		USD
	igap	Debt Instruments Convertible Interest Expense DebtInstrumentsConvertibleInterestExpense	200812	USD
CY2013	igap	Debt Instruments Convertible Interest Expense DebtInstrumentsConvertibleInterestExpense		USD
CY2011	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	30893	USD
CY2012	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-1291	USD
	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	8568651	USD
CY2013	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	6768959	USD
CY2012Q4	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	119488	USD
CY2013Q4	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	170033	USD
CY2011	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	14436	USD
CY2012	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-6387	USD
	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-149221	USD
CY2013	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-40029	USD
CY2010	igap	Issuance Of Common Stock For Cash In December2010 Net Of Related Expenses Value IssuanceOfCommonStockForCashInDecember2010NetOfRelatedExpensesValue	2357032	USD
CY2009	igap	Issuance Of Common Stock For Cash In January2009 Value IssuanceOfCommonStockForCashInJanuary2009Value	303000	USD
CY2004	igap	Issuance Of Common Stock For Cash March162004 Value IssuanceOfCommonStockForCashMarch162004Value	75000	USD
CY2011	igap	Issuance Of Common Stock For Cash On April292011 Net Of Related Expenses Value IssuanceOfCommonStockForCashOnApril292011NetOfRelatedExpensesValue	191722	USD
CY2005	igap	Issuance Of Common Stock For Cash On April52005 Value IssuanceOfCommonStockForCashOnApril52005Value	500000	USD
CY2006	igap	Issuance Of Common Stock For Cash On August152006 Value IssuanceOfCommonStockForCashOnAugust152006Value	200000	USD
CY2006	igap	Issuance Of Common Stock For Cash On December142006 Value IssuanceOfCommonStockForCashOnDecember142006Value	1372495	USD
CY2012	igap	Issuance Of Common Stock For Cash One Value IssuanceOfCommonStockForCashOneValue	917179	USD
CY2005	igap	Issuance Of Common Stock For Cash On January142005 Value IssuanceOfCommonStockForCashOnJanuary142005Value	375000	USD
CY2006	igap	Issuance Of Common Stock For Cash On January262006 Value IssuanceOfCommonStockForCashOnJanuary262006Value	128205	USD
CY2011	igap	Issuance Of Common Stock For Cash On January312011 Net Of Related Expenses Value IssuanceOfCommonStockForCashOnJanuary312011NetOfRelatedExpensesValue	83180	USD
CY2011	igap	Issuance Of Common Stock For Cash On July292011 Net Of Related Expenses Value IssuanceOfCommonStockForCashOnJuly292011NetOfRelatedExpensesValue	1466385	USD
CY2006	igap	Issuance Of Common Stock For Cash On June162006 Value IssuanceOfCommonStockForCashOnJune162006Value	50000	USD
CY2006	igap	Issuance Of Common Stock For Cash On June302006 Value IssuanceOfCommonStockForCashOnJune302006Value	51180	USD
CY2006	igap	Issuance Of Common Stock For Cash On March312006 Value IssuanceOfCommonStockForCashOnMarch312006Value	6890	USD
CY2011	igap	Issuance Of Common Stock For Cash On March312011 Net Of Related Expenses Value IssuanceOfCommonStockForCashOnMarch312011NetOfRelatedExpensesValue	479901	USD
CY2005	igap	Issuance Of Common Stock For Cash On May312005 Value IssuanceOfCommonStockForCashOnMay312005Value	200000	USD
CY2011	igap	Issuance Of Common Stock For Cash On May312011 Net Of Related Expenses Value IssuanceOfCommonStockForCashOnMay312011NetOfRelatedExpensesValue	180026	USD
CY2004	igap	Issuance Of Common Stock For Cash On November252004 Value IssuanceOfCommonStockForCashOnNovember252004Value	128856	USD
CY2006	igap	Issuance Of Common Stock For Cash On October52006 Value IssuanceOfCommonStockForCashOnOctober52006Value	1300000	USD
CY2008	igap	Issuance Of Common Stock For Cash On October72008 Value IssuanceOfCommonStockForCashOnOctober72008Value	500000	USD
CY2008	igap	Issuance Of Common Stock For Cash On September272008 Value IssuanceOfCommonStockForCashOnSeptember272008Value	342000	USD
	igap	Issuance Of Common Stock For Cash September302001 Value IssuanceOfCommonStockForCashSeptember302001Value	40442	USD
CY2011	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	24934	USD
CY2012	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	9849	USD
	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	201280	USD
CY2013	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	14382	USD
CY2013Q4	igap	Monthly Lease Commitment MonthlyLeaseCommitment	3300	USD
CY2013Q4	igap	Monthly Lease Commitment MonthlyLeaseCommitment	11500	ILS
CY2012Q4	igap	Number Of Shares Offered NumberOfSharesOffered	785714	shares
CY2013Q1	igap	Number Of Units Sold NumberOfUnitsSold	6300	shares
CY2013Q2	igap	Number Of Units Sold NumberOfUnitsSold	1140.35	shares
CY2013	igap	Percent Of Future Sales Designated To Repay Stockholders Loans PercentOfFutureSalesDesignatedToRepayStockholdersLoans	0.1	pure
CY2011	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	2401214	USD
CY2012	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	917179	USD
	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	11323559	USD
CY2013	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts		USD
CY2009	igap	Repayment Of Receivable In Respect Of Stock Issuance RepaymentOfReceivableInRespectOfStockIssuance	75000	USD
CY2010	igap	Stockbased Interest Compensation To Convertible Notes Holders Value StockbasedInterestCompensationToConvertibleNotesHoldersValue	1214943	USD
CY2013	igap	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	23200	USD
CY2013Q4	igap	Stock Price At Which Stock Dividend Is Declared StockPriceAtWhichStockDividendIsDeclared	5.80
CY2013	igap	Temporary Equity Adjustments For Issuance Costs TemporaryEquityAdjustmentsForIssuanceCosts	171877	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	122537	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	49787	USD
CY2012Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	25667	USD
CY2013Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	41702	USD
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	96870	USD
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	8085	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	113595	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44093	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	154252	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	198439	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8925	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	52702	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14772371	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14532068	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-83899	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	48007	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	562805	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	582732	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600232	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2813493	shares
CY2012Q4	us-gaap	Assets Assets	814571	USD
CY2013Q4	us-gaap	Assets Assets	2756205	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	624883	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2478963	USD
CY2001Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1494248	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896504	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	543411	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385911	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	402256	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1353093	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2385911	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1842500	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2005Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5460600	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5301693	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5460600	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5301693	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	5461	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	5302	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2403391	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2758598	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25139381	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9840630	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 68.1pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> O.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Concentrations of credit risk</div> </td> </tr> </table> </div> <div> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 94.95pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Financial instruments that potentially subject the Group to concentrations of credit risk consist primarily of cash and cash equivalents.  Cash and cash equivalents are deposited with major banks in Israel and the United States of America. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Group does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div>
CY2013	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1140186	USD
CY2013	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	23.2	shares
CY2013	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4000	shares
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2890426	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3496123	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4364466	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	42137	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	47440	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	33629	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2932563	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3543563	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4398095	USD
CY2011	us-gaap	Depreciation Depreciation	23045	USD
CY2012	us-gaap	Depreciation Depreciation	25546	USD
	us-gaap	Depreciation Depreciation	191717	USD
CY2013	us-gaap	Depreciation Depreciation	33684	USD
CY2013	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	278263	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	288248	USD
CY2013	us-gaap	Dividends Stock DividendsStock		USD
CY2012Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	630575	USD
CY2013Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	693092	USD
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.95
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-23993	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8103	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	228602	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	108656	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	184394	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	217027	USD
	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.001
CY2004Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.76
CY2006Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	3.63
CY2006Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	3.91
CY2006Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	4.31
CY2006Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	4.31
CY2008Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	5.52
CY2008Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	5.52
CY2009Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.02
CY2010Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2004Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.72
CY2005Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.72
CY2005Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.72
CY2005Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	3.37
CY2006Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.47
CY2006Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	3.63
CY2006Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	3.63
CY2010Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2011Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2011Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2011Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2011Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2011Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2010Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	6.25
CY2012Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	7.00
CY2011	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		USD
CY2012	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-35892	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6215350	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6251242	USD
CY2011	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4638	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18147	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-346859	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-94815	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	912	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	544145	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	852908	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4055782	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1041140	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2364339	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2772307	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9796853	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2011	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	236434	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	277231	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	253942	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-827519	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-970307	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3428899	USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4885	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4553	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	21250	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2324760	USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	132325	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	122333	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	10570	USD
CY2011	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	453875	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	566190	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	818377	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	64697	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	48850	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	44733	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-77259	USD
CY2011	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	78192	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
CY2011	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	23968	USD
CY2012	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-14106	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	74652	USD
CY2013	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5234	USD
CY2011	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-19681	USD
CY2012	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	80574	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	233643	USD
CY2013	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-54317	USD
CY2011	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	1127	USD
CY2012	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-17237	USD
	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	196506	USD
CY2013	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-9959	USD
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	10597	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	6605	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	-1521	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	17592	USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	562805	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1317640	USD
CY2013Q4	us-gaap	Liabilities Liabilities	9456778	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	814571	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2756205	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	457953	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	310907	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	859687	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9145871	USD
CY2013Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	86430	USD
CY2013Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000	ILS
CY2011	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		USD
CY2012	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	12920	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2382545	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	953527	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17373927	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5055892	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-40183	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-17734	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-424791	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-104281	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1916113	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2296989	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-14791827	USD
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-288233	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3217767	USD
	us-gaap	Net Income Loss NetIncomeLoss	-63293	USD
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-350290	USD
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-1055594	USD
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-1282842	USD
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-1593205	USD
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-1528981	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-1202296	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-2788446	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-2364339	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-2772307	USD
	us-gaap	Net Income Loss NetIncomeLoss	-25086679	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9796853	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2364339	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2772307	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10363363	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-2333446	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-2773598	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16518028	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-3027894	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	81472	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	93052	USD
CY2011	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39052	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13709	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-52702	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-43777	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5	USD
CY2003	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15035	USD
CY2004	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15069	USD
CY2005	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8542	USD
CY2006	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-57127	USD
CY2007	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	84528	USD
CY2008	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	110134	USD
CY2009	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13367	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-119019	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	39052	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13709	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43777	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	297989	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	261120	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	390928	USD
CY2013	us-gaap	Other Noncash Expense OtherNoncashExpense	390928	USD
CY2011	us-gaap	Other Operating Income OtherOperatingIncome		USD
CY2012	us-gaap	Other Operating Income OtherOperatingIncome		USD
	us-gaap	Other Operating Income OtherOperatingIncome	912	USD
CY2013	us-gaap	Other Operating Income OtherOperatingIncome		USD
CY2011	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		USD
CY2012	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		USD
CY2013	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	278263	USD
CY2011	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
CY2012	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	1214943	USD
CY2013	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
CY2011	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		USD
CY2012	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	288248	USD
CY2013	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	288248	USD
CY2011	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	388732	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54619	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11347	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	284372	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64252	USD
CY2011	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		USD
CY2012	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		USD
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	14252	USD
CY2013	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		USD
CY2012Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	229112	USD
CY2013Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	236074	USD
CY2011	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	42358	USD
CY2012	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	78556	USD
CY2013	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	91588	USD
CY2011	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
CY2012	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	288247	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29460	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29044	USD
CY2012Q4	us-gaap	Prepaid Taxes PrepaidTaxes	52012	USD
CY2013Q4	us-gaap	Prepaid Taxes PrepaidTaxes	64008	USD
CY2011	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
CY2012	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1144000	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
CY2011	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		USD
CY2012	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	3960958	USD
CY2013	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	3960958	USD
CY2011	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
CY2012	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1421983	USD
CY2013	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1421983	USD
CY2011	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2012	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	347742	USD
CY2013	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2011	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-18669	USD
CY2012	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	36348	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-8671	USD
CY2013	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-38801	USD
CY2013	us-gaap	Proceeds From Repurchase Of Redeemable Preferred Stock ProceedsFromRepurchaseOfRedeemablePreferredStock	5400000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	406995	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4791	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	224452	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	305648	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	70200	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107209	USD
CY2011	us-gaap	Recapitalization Costs RecapitalizationCosts		USD
CY2012	us-gaap	Recapitalization Costs RecapitalizationCosts		USD
	us-gaap	Recapitalization Costs RecapitalizationCosts	390928	USD
CY2013	us-gaap	Recapitalization Costs RecapitalizationCosts	390928	USD
CY2012Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		USD
CY2013Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	4362545	USD
CY2011	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
CY2012	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	527396	USD
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
CY2011	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	1789301	USD
CY2012	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	1920690	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	12556620	USD
CY2013	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	1986754	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1789301	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1920690	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12463158	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1986754	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15289826	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25653190	USD
CY2004	us-gaap	Revenue From Grants RevenueFromGrants	93462	USD
CY2011	us-gaap	Revenue From Grants RevenueFromGrants		USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants		USD
	us-gaap	Revenue From Grants RevenueFromGrants	93462	USD
CY2013	us-gaap	Revenue From Grants RevenueFromGrants		USD
CY2013	us-gaap	Revenue Recognition Services Royalty Fees RevenueRecognitionServicesRoyaltyFees	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 68.1pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> J.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Royalty-bearing grants</div> </td> </tr> </table> </div> <div> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 94.95pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Royalty-bearing grants from the OCS for funding approved research and development projects are recognized at the time Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs.  The cumulative research and development grants received by Integrity Israel from inception through December 2004 amounted to $93,462.  Integrity Israel has not received any research and development grants since December 2004.</div> </td> </tr> </table> </div> <div> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 94.95pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> As of December 31, 2013, 2012 and 2011, the Group did not accrue or pay any royalties to the OCS.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div>
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	378072	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	349522	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1616044	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	35619	USD
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	298910	shares
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	414847	shares
CY2012Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	37427	USD
CY2013Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		USD
CY2001Q3	us-gaap	Stockholders Equity StockholdersEquity		USD
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	-22856	USD
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	-388181	USD
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	-487627	USD
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	-270063	USD
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	1776235	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	542217	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	49750	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-775742	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	598139	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	968239	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-503069	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-11063118	USD
CY2010	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2.1363	pure
CY2013	us-gaap	Stockholders Equity Other StockholdersEquityOther	1140349	USD
CY2010Q4	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	48000	shares
CY2011Q1	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	16320	shares
CY2011Q1	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	90768	shares
CY2011Q2	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	40000	shares
CY2011Q2	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	34200	shares
CY2011Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	269680	shares
CY2010Q4	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	482600	shares
CY2012Q4	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	165057	shares
CY2010	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	694796	USD
CY2010Q4	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	300000	USD
CY2011Q1	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	102000	USD
CY2011Q1	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	567300	USD
CY2011Q2	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	250000	USD
CY2011Q2	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	213750	USD
CY2011Q3	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1685500	USD
CY2010Q4	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	3016250	USD
CY2012Q4	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1155399	USD
CY2005	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	189616	USD
CY2006	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	277497	USD
CY2007	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	274659	USD
CY2008	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	84380	USD
CY2009	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12171	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14575	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	378072	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	349522	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35619	USD
CY2013Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	162907	shares
CY2013	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-23200	USD
CY2013Q2	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1140139	USD
CY2012Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2013Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	7417	shares
CY2012Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2013Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7417	shares
CY2011	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	35892	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-6215350	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-6251242	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 68.05pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> A.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Use of estimates in the preparation of financial statements</div> </td> </tr> </table> </div> <div> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 94.95pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">  </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (a) the allocation of the proceeds and the related issuance costs of Units consisting of convertible Preferred Stock and warrants with down round protection, (b) the fair value estimate of the warrants with the down-round protection and (c) the going concern assumptions.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div>
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		USD
CY2013Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8216705	USD
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5091330	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5314800	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5325714	shares

Files In Submission

Name	View Source	Status
0001178913-14-001124-index-headers.html	Edgar Link	pending
0001178913-14-001124-index.html	Edgar Link	pending
0001178913-14-001124.txt	Edgar Link	pending
0001178913-14-001124-xbrl.zip	Edgar Link	pending
exhibit_10-15.htm	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
figurea.jpg	Edgar Link	pending
figureb.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grant_thorntonpahnkanne.jpg	Edgar Link	pending
igap-20131231.xml	Edgar Link	completed
igap-20131231.xsd	Edgar Link	pending
igap-20131231_cal.xml	Edgar Link	unprocessable
igap-20131231_def.xml	Edgar Link	unprocessable
igap-20131231_lab.xml	Edgar Link	unprocessable
igap-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1414629.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GCTK
GlucoTrack Inc Stock $gctk

2014 Q1 Form 10-K Financial Statement

#000117891314001124 Filed on March 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK GlucoTrack Inc Stock $gctk

2014 Q1 Form 10-K Financial Statement

#000117891314001124 Filed on March 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK
GlucoTrack Inc Stock $gctk